SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 110 filers reported holding TRANSMEDICS GROUP INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q4 2022$624,668
+48.0%
10,1210.0%0.01%
+57.1%
Q3 2022$422,000
-48.5%
10,121
-66.7%
0.01%
-56.2%
Q1 2022$820,000
+110.8%
30,432
+49.8%
0.02%
+60.0%
Q4 2021$389,000
-51.6%
20,311
-16.5%
0.01%
-33.3%
Q3 2021$804,00024,3110.02%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q1 2022
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders